Filing Flows › BioAge Labs (BIOA) › Q3 2025
BioAge Labs (BIOA) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 6, 2025
BioAge Labs (BIOA) reported revenue of $2.1M for the third quarter 2025 (Q3 2025) and -15% from the quarter before.
BioAge Labs, Q3 2025: revenue $2.1M, net loss $20.2M, operating cash flow −$16.0M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.1M | -15% | — |
| Operating profit | −$23.1M | — | — |
| Net earnings | −$20.2M | — | — |
| Operating cash flow | −$16.0M | — | — |
What changed
Revenue was $2.1M in Q3 2025, down 15% from the previous quarter.
Operating costs exceeded revenue by $23.1M, an operating margin of -1126.6%. The quarter ended with a net loss of $20.2M, narrower than the previous quarter's $21.6M loss.
Operating cash flow was −$16.0M. Non-cash charges added back $2.8M of share-based compensation. Working capital and other items added $1.3M. Capital expenditures of $22K exceeded it, leaving free cash flow of −$16.1M.
Questions
What was BioAge Labs' revenue in the third quarter 2025?
BioAge Labs (BIOA) reported revenue of $2.1M for the third quarter 2025 (Q3 2025) and -15% from the quarter before.
Source: BioAge Labs 10-Q on SEC EDGAR.